Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹3,348.60
41.00 (1.24%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹41.84K Cr
MID CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
39.1
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹2,329.9+43.7%
52W High₹3,506.9-4.5%
Current Price
₹3,348.60
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹2,678.88
Upper Circuit₹4,018.32
Reference Price
₹3,348.60
Investment Checklist
Rounding Bottom on 1D (BREAKOUT CONFIRMED) — target ₹3458.55
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹3757.0
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bullish (price down, volume up)
Composite score 39.12 (BUY) with 80.9% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
81%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
3250.41
EMA50
3132.54
EMA200
2872.12
Price Action
MIXED
NEUTRAL
Higher Highs3
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹3506.90
Support (Below)
₹3314.90
₹3228.00
₹3178.90
₹3054.00
₹3020.80
Volume Analysis
TrendINCREASING
Change+76.30%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹3315.11
3% Risk₹3248.14
5% Risk₹3181.17
7% Risk (Custom)
₹3114.20Technical Levels
1x ATR (Volatility)₹3235.05
2x ATR (Swing)₹3121.50
3x ATR (Trend)₹3007.95
Immediate Support₹3314.90
Moving Averages
EMA 9 (Short-term)₹3311.77
EMA 20 (Medium-term)₹3250.41
EMA 50 (Trend)₹3132.54
EMA 200 (Long-term)₹2872.12
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹1,146.1 Cr | ₹1,109.8 Cr | ₹1,302.7 Cr | ₹1,374.8 Cr |
| Net Profit | ₹232.9 Cr | ₹225.3 Cr | ₹255.3 Cr | ₹273.8 Cr |
| EPS | ₹18.60 | — | ₹20.44 | ₹21.91 |
| Operating Profit | ₹351.3 Cr | ₹315.3 Cr | ₹377.7 Cr | ₹407.2 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Ajanta Pharma Limited | ₹3,348.60 | +1.24% | 39.1 | ₹41.84K Cr mid Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 10 Nov 2025 | Interim Dividend - Rs 28 Per Share | INTERIM_DIVIDEND |
| 06 Nov 2024 | Interim Dividend - Rs 28 Per Share | INTERIM_DIVIDEND |
| 30 May 2024 | Buy Back | BUYBACK |
| 08 Feb 2024 | Interim Dividend - Rs 26 Per Share | INTERIM_DIVIDEND |
| 04 Aug 2023 | Interim Dividend - Rs 10 Per Share/Special Dividend - Rs 15 Per Share | SPECIAL_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for AJANTPHARM
View All
neutral
ET Markets - Stocks 7d ago
Inspira seals Rs 1,800-crore private credit for Burger King buy in India
Inspira Global, backed by Ajanta Pharma promoters, is securing ₹1,800 crore in private credit to acquire a controlling stake in India's Burger King operator. The food business, through its arm Lenexis Foodworks, has already raised ₹1,050 crore via NCDs, with the remaining ₹800 crore anticipated this month. This significant funding signals a major move into the quick-service restaurant sector.
AJANTPHARMGLOBALSERVICEConsumer ServicesHealthcare
positive
Business Standard - Markets 12d ago
Nifty Pharma index up 2%; Dr Reddy's, Ajanta, Ipca, Cipla surge up to 5%
In the past seven trading days, the Nifty Pharma index outperformed the market by soaring 5.4 per cent, as compared to 0.1 per cent decline in the Nifty 50.
AJANTPHARMAONETMMQ50AONETOTALBANKIETFCIPLAMOCAPITALPHARMABEESPVTBANIETFFinancial ServicesHealthcare
neutral
Google News - India Markets 31d ago
Stocks to watch: Ajanta Pharma, Bharti Airtel, IndiGo, NLC India, among key stocks in focus on 10 June - Mint
Stocks to watch: Ajanta Pharma, Bharti Airtel, IndiGo, NLC India, among key stocks in focus on 10 JuneMint
AJANTPHARMBHARTIARTLFOCUSINDIGONLCINDIAConsumer DurablesHealthcare